A role for selective serotonin reuptake inhibitors in the management of residual cognitive dysfunction in pediatric Cushing's disease

J Child Adolesc Psychopharmacol. 2013 Feb;23(1):65-9. doi: 10.1089/cap.2012.0037.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Cognition Disorders / complications
  • Cognition Disorders / drug therapy*
  • Female
  • Fluoxetine / therapeutic use*
  • Humans
  • Pituitary ACTH Hypersecretion / complications
  • Pituitary ACTH Hypersecretion / drug therapy*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

  • Serotonin Uptake Inhibitors
  • Fluoxetine